Cardiometabolic factors’ and cardiovascular risk in young adult cancer survivors: evidence from real-world data - Report - MDSpire

Cardiometabolic factors’ and cardiovascular risk in young adult cancer survivors: evidence from real-world data

  • By

  • Samah Hayek

  • Jinyi Li

  • Jiahui Dai

  • Joel Milam

  • Luohua Jiang

  • August 12, 2025

  • 0 min

Share

Cardiometabolic Risk and Cardiovascular Health in Young Adult Cancer Survivors

Overview

Young adult cancer survivors exhibit a higher prevalence of cardiometabolic risk factors such as type 2 diabetes, hypertension, hyperlipidaemia, and obesity compared to matched non-cancer peers. These factors significantly increase the risk of cardiovascular diseases including myocardial infarction and congestive heart failure, with notable racial and ethnic disparities.

Background

Advances in cancer therapies have improved survival rates among young adults diagnosed between ages 19 and 39, but survivors face increased long-term cardiovascular risks. Cancer treatments can induce metabolic changes that elevate classical cardiovascular risk factors. Cardiometabolic syndrome, comprising obesity, hypertension, hyperlipidaemia, and diabetes, is a major contributor to cardiovascular disease risk and may develop earlier or more frequently in young adult cancer survivors. Understanding these risks is critical for improving survivorship care and reducing cardiovascular morbidity.

Data Highlights

Cardiometabolic FactorOdds Ratio (OR) for MI95% CI for MIOR for CHF95% CI for CHF
Type 2 Diabetes (T2DM)6.993.45–14.1912.3047.23–20.91
HypertensionNot specifiedNot specified20.4811.79–35.57

Key Findings

  • Young adult cancer survivors have a higher prevalence of cardiometabolic risk factors compared to matched non-cancer individuals.
  • Type 2 diabetes in survivors is associated with nearly sevenfold increased odds of myocardial infarction and over twelvefold increased odds of congestive heart failure.
  • Hypertension is strongly linked to congestive heart failure with an odds ratio exceeding 20.
  • Cardiometabolic factors independently elevate cardiovascular disease risk beyond the effects of cancer treatment alone.
  • Racial and ethnic disparities exist in the prevalence and impact of cardiometabolic risk factors among young adult cancer survivors.

Clinical Implications

These findings highlight the necessity for integrated cardiometabolic risk assessment in survivorship care for young adult cancer survivors. Early screening, lifestyle modification, and targeted management of diabetes, hypertension, and other risk factors should be prioritized alongside cardiac monitoring to mitigate long-term cardiovascular disease risk. Awareness of ethnic disparities can guide personalized prevention strategies.

Conclusion

Cardiometabolic risk factors significantly contribute to elevated cardiovascular disease risk in young adult cancer survivors. Comprehensive survivorship care must incorporate early identification and management of these modifiable risks to improve long-term cardiovascular outcomes.

References

  1. University of California, Irvine Study 2021 -- Cardiometabolic Risk Factors and Cardiovascular Health in Young Adult Survivors of Cancer

Original Source(s)

Related Content